Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Policies for Deprescribing: An International Scan of Intended and Unintended Outcomes of Limiting Sedative-Hypnotic Use in Community-Dwelling Older Adults.

Shaw J, Murphy AL, Turner JP, Gardner DM, Silvius JL, Bouck Z, Gordon D, Tannenbaum C.

Healthc Policy. 2019 May;14(4):39-51. doi: 10.12927/hcpol.2019.25857.

PMID:
31322113
2.

Patients beliefs and attitudes towards deprescribing: can deprescribing success be predicted?

Turner JP, Martin P, Zhang YZ, Tannenbaum C.

Res Social Adm Pharm. 2019 Jul 10. pii: S1551-7411(19)30102-0. doi: 10.1016/j.sapharm.2019.07.007. [Epub ahead of print]

PMID:
31303479
3.
4.

Improving care for elderly patients living with polypharmacy: protocol for a pragmatic cluster randomized trial in community-based primary care practices in Canada.

Greiver M, Dahrouge S, O'Brien P, Manca D, Lussier MT, Wang J, Burge F, Grandy M, Singer A, Twohig M, Moineddin R, Kalia S, Aliarzadeh B, Ivers N, Garies S, Turner JP, Farrell B.

Implement Sci. 2019 Jun 6;14(1):55. doi: 10.1186/s13012-019-0904-4.

5.

Exploration of home care nurse's experiences in deprescribing of medications: a qualitative descriptive study.

Sun W, Tahsin F, Barakat-Haddad C, Turner JP, Haughian CR, Abbass-Dick J.

BMJ Open. 2019 May 24;9(5):e025606. doi: 10.1136/bmjopen-2018-025606.

6.

Deprescribing conversations: a closer look at prescriber-patient communication.

Turner JP, Richard C, Lussier MT, Lavoie ME, Farrell B, Roberge D, Tannenbaum C.

Ther Adv Drug Saf. 2018 Oct 20;9(12):687-698. doi: 10.1177/2042098618804490. eCollection 2018 Dec.

7.

Strategies to promote public engagement around deprescribing.

Turner JP, Currie J, Trimble J, Tannenbaum C.

Ther Adv Drug Saf. 2018 Sep 12;9(11):653-665. doi: 10.1177/2042098618794165. eCollection 2018 Nov. Review.

8.

Does a Consumer-Targeted Deprescribing Intervention Compromise Patient-Healthcare Provider Trust?

Zhang YZ, Turner JP, Martin P, Tannenbaum C.

Pharmacy (Basel). 2018 Apr 16;6(2). pii: E31. doi: 10.3390/pharmacy6020031.

9.

Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data.

Koleti A, Terryn R, Stathias V, Chung C, Cooper DJ, Turner JP, Vidovic D, Forlin M, Kelley TT, D'Urso A, Allen BK, Torre D, Jagodnik KM, Wang L, Jenkins SL, Mader C, Niu W, Fazel M, Mahi N, Pilarczyk M, Clark N, Shamsaei B, Meller J, Vasiliauskas J, Reichard J, Medvedovic M, Ma'ayan A, Pillai A, Schürer SC.

Nucleic Acids Res. 2018 Jan 4;46(D1):D558-D566. doi: 10.1093/nar/gkx1063.

10.

Drug target ontology to classify and integrate drug discovery data.

Lin Y, Mehta S, Küçük-McGinty H, Turner JP, Vidovic D, Forlin M, Koleti A, Nguyen DT, Jensen LJ, Guha R, Mathias SL, Ursu O, Stathias V, Duan J, Nabizadeh N, Chung C, Mader C, Visser U, Yang JJ, Bologa CG, Oprea TI, Schürer SC.

J Biomed Semantics. 2017 Nov 9;8(1):50. doi: 10.1186/s13326-017-0161-x.

11.

A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.

Reeve E, Moriarty F, Nahas R, Turner JP, Kouladjian O'Donnell L, Hilmer SN.

Expert Opin Drug Saf. 2018 Jan;17(1):39-49. doi: 10.1080/14740338.2018.1397625. Epub 2017 Nov 6. Review.

PMID:
29072544
12.

Older Adults' Awareness of Deprescribing: A Population-Based Survey.

Turner JP, Tannenbaum C.

J Am Geriatr Soc. 2017 Dec;65(12):2691-2696. doi: 10.1111/jgs.15079. Epub 2017 Sep 15.

13.

Is my older cancer patient on too many medications?

Turner JP, Shakib S, Bell JS.

J Geriatr Oncol. 2017 Mar;8(2):77-81. doi: 10.1016/j.jgo.2016.10.003. Epub 2016 Nov 11. Review.

PMID:
27840102
14.

Modulating amyloid-β aggregation: The effects of peptoid side chain placement and chirality.

Turner JP, Chastain SE, Park D, Moss MA, Servoss SL.

Bioorg Med Chem. 2017 Jan 1;25(1):20-26. doi: 10.1016/j.bmc.2016.10.007. Epub 2016 Oct 10.

PMID:
27776890
15.

Pediatric Pulmonary Embolism: Diagnostic and Management Challenges.

Lilje C, Chauhan A, Turner JP, Carson TH, Velez MC, Arcement C, Caspi J.

World J Pediatr Congenit Heart Surg. 2018 Jan;9(1):110-113. doi: 10.1177/2150135116663698. Epub 2016 Sep 12.

PMID:
27619327
16.

Factors associated with use of falls risk-increasing drugs among patients of a geriatric oncology outpatient clinic in Australia: a cross-sectional study.

Turner JP, Tervonen HE, Shakib S, Singhal N, Prowse R, Bell JS.

J Eval Clin Pract. 2017 Apr;23(2):361-368. doi: 10.1111/jep.12624. Epub 2016 Aug 24.

PMID:
27554195
17.

What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals.

Turner JP, Edwards S, Stanners M, Shakib S, Bell JS.

BMJ Open. 2016 Mar 10;6(3):e009781. doi: 10.1136/bmjopen-2015-009781.

18.

Are residents of aged care facilities willing to have their medications deprescribed?

Kalogianis MJ, Wimmer BC, Turner JP, Tan EC, Emery T, Robson L, Reeve E, Hilmer SN, Bell JS.

Res Social Adm Pharm. 2016 Sep-Oct;12(5):784-8. doi: 10.1016/j.sapharm.2015.12.004. Epub 2015 Dec 19.

PMID:
26850702
19.

Polypharmacy cut-points in older people with cancer: how many medications are too many?

Turner JP, Jamsen KM, Shakib S, Singhal N, Prowse R, Bell JS.

Support Care Cancer. 2016 Apr;24(4):1831-40. doi: 10.1007/s00520-015-2970-8. Epub 2015 Oct 9.

PMID:
26449548
20.

Analgesic Use and Pain in Robust, Pre-Frail and Frail Older Outpatients with Cancer.

Jamsen KM, Turner JP, Shakib S, Singhal N, Hogan-Doran J, Prowse R, Johns S, Bell JS.

Drugs Real World Outcomes. 2015 Jun;2(2):117-121.

21.

Patients' perspectives on the brave new word 'deprescribing'.

Reeve E, Turner JP.

Int J Pharm Pract. 2015 Feb;23(1):90-1. doi: 10.1111/ijpp.12111. No abstract available.

PMID:
25594318
22.

Statin use and pain in older people with cancer: a cross-sectional study.

Turner JP, Shakib S, Singhal N, Hogan-Doran J, Prowse R, Johns S, Thynne T, Bell JS.

J Am Geriatr Soc. 2014 Oct;62(10):1900-5. doi: 10.1111/jgs.13051. Epub 2014 Oct 3.

PMID:
25284040
23.

Potentially inappropriate medication use in older people with cancer: prevalence and correlates.

Saarelainen LK, Turner JP, Shakib S, Singhal N, Hogan-Doran J, Prowse R, Johns S, Lees J, Bell JS.

J Geriatr Oncol. 2014 Oct 1;5(4):439-46. doi: 10.1016/j.jgo.2014.07.001. Epub 2014 Aug 7.

PMID:
25127252
24.

Rationally designed peptoids modulate aggregation of amyloid-beta 40.

Turner JP, Lutz-Rechtin T, Moore KA, Rogers L, Bhave O, Moss MA, Servoss SL.

ACS Chem Neurosci. 2014 Jul 16;5(7):552-8. doi: 10.1021/cn400221u. Epub 2014 Apr 16.

25.

Prevalence and factors associated with polypharmacy in older people with cancer.

Turner JP, Shakib S, Singhal N, Hogan-Doran J, Prowse R, Johns S, Bell JS.

Support Care Cancer. 2014 Jul;22(7):1727-34. doi: 10.1007/s00520-014-2171-x. Epub 2014 Mar 2. Erratum in: Support Care Cancer. 2014 Jul;22(7):1735.

PMID:
24584682
26.

Structure-based virtual screening for novel ligands.

Pitt WR, Calmiano MD, Kroeplien B, Taylor RD, Turner JP, King MA.

Methods Mol Biol. 2013;1008:501-19. doi: 10.1007/978-1-62703-398-5_19.

PMID:
23729265
27.

Tunable peptoid microspheres: effects of side chain chemistry and sequence.

Hebert ML, Shah DS, Blake P, Turner JP, Servoss SL.

Org Biomol Chem. 2013 Jul 21;11(27):4459-64. doi: 10.1039/c3ob40561c.

PMID:
23715089
28.

Implementation of pharmacist-led medication reviews in general practice.

Turner JP, Bell JS.

Int J Clin Pharm. 2013 Feb;35(1):3-4. doi: 10.1007/s11096-012-9721-4. Epub 2012 Nov 6. No abstract available.

PMID:
23129419
29.

Generation of a human embryonic stem cell line stably expressing high levels of the fluorescent protein mCherry.

Ovchinnikov DA, Turner JP, Titmarsh DM, Thakar NY, Sin DC, Cooper-White JJ, Wolvetang EJ.

World J Stem Cells. 2012 Jul 26;4(7):71-9.

30.

Thoracic emergencies. Preface.

Turner JP.

Emerg Med Clin North Am. 2012 May;30(2):xv-xvi. doi: 10.1016/j.emc.2012.01.001. Epub 2012 Feb 1. No abstract available.

PMID:
22487120
31.

Thoracic ultrasound.

Turner JP, Dankoff J.

Emerg Med Clin North Am. 2012 May;30(2):451-73, ix. doi: 10.1016/j.emc.2011.12.003. Review.

PMID:
22487114
32.

Overcoming obstacles to resident-patient continuity of care.

Turner JP, Rodriguez HE, Daskin MS, Mehrotra S, Speicher P, DaRosa DA.

Ann Surg. 2012 Apr;255(4):618-22. doi: 10.1097/SLA.0b013e3182468dcf.

PMID:
22311130
33.

Audiogram of a stranded Blainville's beaked whale (Mesoplodon densirostris) measured using auditory evoked potentials.

Pacini AF, Nachtigall PE, Quintos CT, Schofield TD, Look DA, Levine GA, Turner JP.

J Exp Biol. 2011 Jul 15;214(Pt 14):2409-15. doi: 10.1242/jeb.054338.

34.

A model for evaluating resident education with a focus on continuity of care and educational quality.

Rodriguez H, Turner JP, Speicher P, Daskin MS, Darosa D.

J Surg Educ. 2010 Nov-Dec;67(6):352-8. doi: 10.1016/j.jsurg.2010.09.004. Epub 2010 Nov 7. No abstract available.

PMID:
21156291
35.

Ascorbate promotes epigenetic activation of CD30 in human embryonic stem cells.

Chung TL, Turner JP, Thaker NY, Kolle G, Cooper-White JJ, Grimmond SM, Pera MF, Wolvetang EJ.

Stem Cells. 2010 Oct;28(10):1782-93. doi: 10.1002/stem.500.

36.

Delayed intrathyroidal hematoma causing respiratory distress after a seemingly benign fall: a case report.

Chartier LB, Turner JP.

Int J Emerg Med. 2010 Jul 8;3(4):431-3. doi: 10.1007/s12245-010-0196-6.

37.

Recruitment of local excitatory circuits in the superior colliculus following deafferentation and the regeneration of retinocollicular inputs.

Turner JP, Sauvé Y, Varela-Rodriguez C, Lund RD, Salt TE.

Eur J Neurosci. 2005 Oct;22(7):1643-54.

PMID:
16197505
38.
39.

Engineering of Escherichia coli to improve the purification of periplasmic Fab' fragments: changing the pI of the chromosomally encoded PhoS/PstS protein.

Humphreys DP, Heywood SP, King LM, Bowering LC, Turner JP, Lane SE.

Protein Expr Purif. 2004 Sep;37(1):109-18.

PMID:
15294288
40.
42.
43.

Novel neuronal and astrocytic mechanisms in thalamocortical loop dynamics.

Crunelli V, Blethyn KL, Cope DW, Hughes SW, Parri HR, Turner JP, Tòth TI, Williams SR.

Philos Trans R Soc Lond B Biol Sci. 2002 Dec 29;357(1428):1675-93. Review.

44.

Letter codes, structures, masses, and derviatives of amino acids.

Turner JP.

Methods Mol Biol. 2003;211:431-64. No abstract available.

PMID:
12489449
45.
47.

Evaluation of agonists and antagonists acting at Group I metabotropic glutamate receptors in the thalamus in vivo.

Salt TE, Turner JP, Kingston AE.

Neuropharmacology. 1999 Oct;38(10):1505-10.

PMID:
10530812
48.

SHO experience in general practice.

Cunningham WF, Harrigan P, Morgan DC, Turner JP.

J R Coll Physicians Lond. 1999 Jul-Aug;33(4):401. No abstract available.

PMID:
10472035

Supplemental Content

Loading ...
Support Center